Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prospective correlation between the patient microbiome with response to and development of immune-mediated adverse effects to immunotherapy in lung cancer
Authors
Keywords
-
Journal
BMC CANCER
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-07-14
DOI
10.1186/s12885-021-08530-z
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Relating Gut Microbiome and Its Modulating Factors to Immunotherapy in Solid Tumors: A Systematic Review
- (2021) Chengliang Huang et al. Frontiers in Oncology
- Using MicrobiomeAnalyst for comprehensive statistical, functional, and meta-analysis of microbiome data
- (2020) Jasmine Chong et al. Nature Protocols
- The Cross-Talk Between Gut Microbiota and Lungs in Common Lung Diseases
- (2020) Dapeng Zhang et al. Frontiers in Microbiology
- Staphylococci in the human microbiome: the role of host and interbacterial interactions
- (2020) Michael Otto CURRENT OPINION IN MICROBIOLOGY
- The microbiome and lung cancer
- (2019) Abhiram Maddi et al. Journal of Thoracic Disease
- The microbiome, cancer, and cancer therapy
- (2019) Beth A. Helmink et al. NATURE MEDICINE
- Commensal Microbiota Promote Lung Cancer Development via γδ T Cells
- (2019) Chengcheng Jin et al. CELL
- Nod1 imprints inflammatory and carcinogenic responses toward the gastric pathogen Helicobacter pylori
- (2019) Giovanni Suarez et al. CANCER RESEARCH
- Microbiota Transplantation: Targeting Cancer Treatment
- (2019) Xia Wu et al. CANCER LETTERS
- The IL-17 Family of Cytokines in Health and Disease
- (2019) Mandy J. McGeachy et al. IMMUNITY
- The diversity of gut microbiome is associated with favorable responses to anti-PD-1 immunotherapy in Chinese non-small cell lung cancer patients
- (2019) Yueping Jin et al. Journal of Thoracic Oncology
- Microbes, metabolites, and the gut–lung axis
- (2019) Anh Thu Dang et al. Mucosal Immunology
- Review: Helicobacter: Inflammation, immunology, and vaccines
- (2019) Philippe Lehours et al. HELICOBACTER
- Gut Microbiome: A Promising Biomarker for Immunotherapy in Colorectal Cancer
- (2019) Sally Temraz et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
- (2019) Yalda Hekmatshoar et al. LIFE SCIENCES
- Staphylococcus aureus Nasal Carriage and Autoimmune Diseases: From Pathogenic Mechanisms to Disease Susceptibility and Phenotype
- (2019) Fulvia Ceccarelli et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Microbiota profile is different for early and invasive colorectal cancer and is consistent throughout the colon
- (2019) Leonardo Zorron Cheng Tao Pu et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
- (2019) Luis Paz-Ares et al. LANCET
- Microbiota Analysis Using Two-step PCR and Next-generation 16S rRNA Gene Sequencing
- (2019) Shailesh K. Shahi et al. Jove-Journal of Visualized Experiments
- NOD1 is required for Helicobacter pylori induction of IL-33 responses in gastric epithelial cells
- (2018) Le Son Tran et al. CELLULAR MICROBIOLOGY
- Dietary Fiber Confers Protection against Flu by Shaping Ly6c − Patrolling Monocyte Hematopoiesis and CD8 + T Cell Metabolism
- (2018) Aurélien Trompette et al. IMMUNITY
- Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer
- (2018) Umang Swami et al. JOURNAL OF IMMUNOTHERAPY
- Gut dysbiosis: a potential link between increased cancer risk in ageing and inflammaging
- (2018) Arya Biragyn et al. LANCET ONCOLOGY
- The commensal microbiome is associated with anti–PD-1 efficacy in metastatic melanoma patients
- (2018) Vyara Matson et al. SCIENCE
- Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate
- (2018) Maik Luu et al. Scientific Reports
- Colonocyte metabolism shapes the gut microbiota
- (2018) Yael Litvak et al. SCIENCE
- Homeostatic Immunity and the Microbiota
- (2017) Yasmine Belkaid et al. IMMUNITY
- Durvalumab after Chemoradiotherapy in Stage III Non–Small-Cell Lung Cancer
- (2017) Scott J. Antonia et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bifidobacteriumcan mitigate intestinal immunopathology in the context of CTLA-4 blockade
- (2017) Feng Wang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion
- (2017) Mariana X. Byndloss et al. SCIENCE
- Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients
- (2017) V. Gopalakrishnan et al. SCIENCE
- Analysis ofFusobacteriumpersistence and antibiotic response in colorectal cancer
- (2017) Susan Bullman et al. SCIENCE
- Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
- (2017) Bertrand Routy et al. SCIENCE
- Gut microbiome interactions with drug metabolism, efficacy, and toxicity
- (2017) Ian D. Wilson et al. Translational Research
- Metagenomic Shotgun Sequencing and Unbiased Metabolomic Profiling Identify Specific Human Gut Microbiota and Metabolites Associated with Immune Checkpoint Therapy Efficacy in Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome
- (2016) J. M. Pitt et al. CANCER RESEARCH
- Linking the Human Gut Microbiome to Inflammatory Cytokine Production Capacity
- (2016) Melanie Schirmer et al. CELL
- DADA2: High-resolution sample inference from Illumina amplicon data
- (2016) Benjamin J Callahan et al. NATURE METHODS
- Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls
- (2016) Jun Chen et al. Scientific Reports
- Th17 Cell Induction by Adhesion of Microbes to Intestinal Epithelial Cells
- (2015) Koji Atarashi et al. CELL
- Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy
- (2015) A. Sivan et al. SCIENCE
- Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota
- (2015) M. Vetizou et al. SCIENCE
- Role of the Microbiota in Immunity and Inflammation
- (2014) Yasmine Belkaid et al. CELL
- Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR–S6K pathway
- (2014) J Park et al. Mucosal Immunology
- Low gut microbiota diversity in early infancy precedes asthma at school age
- (2013) T. R. Abrahamsson et al. CLINICAL AND EXPERIMENTAL ALLERGY
- The SILVA and “All-species Living Tree Project (LTP)” taxonomic frameworks
- (2013) Pelin Yilmaz et al. NUCLEIC ACIDS RESEARCH
- METAGENassist: a comprehensive web server for comparative metagenomics
- (2012) D. Arndt et al. NUCLEIC ACIDS RESEARCH
- Desulfovibrio Bacterial Species Are Increased in Ulcerative Colitis
- (2011) Fiachra Rowan et al. DISEASES OF THE COLON & RECTUM
- Pulmonary-intestinal cross-talk in mucosal inflammatory disease
- (2011) S Keely et al. Mucosal Immunology
- Antibiotic Use and the Risk of Lung Cancer
- (2008) H. Zhang et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Roles of Probiotics and Prebiotics in Colon Cancer Prevention: Postulated Mechanisms and In-vivo Evidence
- (2008) Min-Tze Liong INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More